A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 9,288 shares of CRL stock, worth $1.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,288
Previous 73,383 87.34%
Holding current value
$1.82 Million
Previous $15.2 Million 87.93%
% of portfolio
0.01%
Previous 0.07%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$187.96 - $245.29 $12 Million - $15.7 Million
-64,095 Reduced 87.34%
9,288 $1.83 Million
Q2 2024

Aug 13, 2024

SELL
$206.39 - $268.73 $7.8 Million - $10.2 Million
-37,781 Reduced 33.99%
73,383 $15.2 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $60,445 - $81,208
-297 Reduced 0.27%
111,164 $30.1 Million
Q3 2023

Nov 09, 2023

SELL
$194.44 - $217.61 $4,472 - $5,005
-23 Reduced 0.02%
111,461 $21.8 Million
Q2 2023

Aug 07, 2023

SELL
$183.71 - $210.25 $455,600 - $521,420
-2,480 Reduced 2.18%
111,484 $23.4 Million
Q1 2023

May 11, 2023

SELL
$191.89 - $259.92 $152,168 - $206,116
-793 Reduced 0.69%
113,964 $23 Million
Q4 2022

Feb 08, 2023

BUY
$197.11 - $250.07 $112,352 - $142,539
570 Added 0.5%
114,757 $25 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $3.57 Million - $4.9 Million
19,577 Added 20.69%
114,187 $22.5 Million
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $2.84 Million - $4.2 Million
13,889 Added 17.21%
94,610 $20.2 Million
Q1 2022

May 11, 2022

BUY
$255.51 - $362.11 $2.61 Million - $3.7 Million
10,207 Added 14.48%
80,721 $22.9 Million
Q4 2021

Feb 10, 2022

SELL
$351.38 - $448.68 $2.66 Million - $3.4 Million
-7,568 Reduced 9.69%
70,514 $26.5 Million
Q3 2021

Nov 10, 2021

BUY
$372.64 - $458.3 $24.1 Million - $29.6 Million
64,665 Added 481.96%
78,082 $32.2 Million
Q2 2021

Aug 10, 2021

BUY
$294.17 - $371.65 $2.33 Million - $2.94 Million
7,911 Added 143.68%
13,417 $4.96 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $83,889 - $100,625
336 Added 6.5%
5,506 $1.6 Million
Q4 2020

Feb 11, 2021

SELL
$222.0 - $252.62 $61,494 - $69,975
-277 Reduced 5.09%
5,170 $1.29 Million
Q3 2020

Nov 12, 2020

BUY
$175.56 - $226.45 $934,681 - $1.21 Million
5,324 Added 4328.46%
5,447 $1.23 Million
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $14,617 - $23,335
123 New
123 $21,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.